By Mark Hamilton, Founder, Neothink Institute · Aging and Disease · June 2026

A life-saving drug now costs one to two billion dollars and more than a decade to reach the patient who needs it, and most of that cost buys nothing but delay. Neovia is the answer the Institute has worked out to that arithmetic: a biotech freedom city on American federal land where the distance between a discovery and the person it cures is measured in months.

What Is Neovia

Neovia is a proposed city built on American federal land, where state-of-the-art laboratories, manufacturing plants, and research campuses operate under one constitutional principle, the Prime Law. It is designed to compress the distance between scientific discovery and patient delivery by removing the regulatory burden that today costs one to two billion dollars and ten or more years for a single therapy.

Neovia begins with a virtual zone. Companies that contract to build receive targeted regulatory relief at once, including accelerated approvals and fast-tracked reimbursement, so therapies can reach Americans before the first brick is laid. Abroad, the same effort advances as part of the broader Immortalis vision.

The Zone Neovia is the discovery-to-deployment cure zone. Immortalis is the end-vision civilization governed by the Prime Law; Neovia is the near-term zone that proves the principle in practice.

The Supply-and-Demand Formula

The path to Neovia began with a question the Institute has examined across 50+ years of research: why do people not clamor to live healthily and happily well into their hundreds? The finding is that most people do not ask for longer life because most are not living the life they want. They hold steady as value creators, capable and hardworking but routine, drifting toward stagnation. A rare few break through to become value creators, who build new value, live with exhilaration, and want more years rather than fewer. The Institute calls this the immortal mentality, and it is the source of genuine demand for longevity.

So the work across 50+ years has been to build the tools that lift ordinary people into value creators, because when people rise, demand for longevity rises with them. The second obstacle is regulatory. Overburdensome regulation makes the supply of longevity crawl: one to two billion dollars and a decade or more per drug. Investors shrink, timelines stretch, and patients wait.

The formula pairs the people's immortal mentality with a governance model that frees progress. With both in place, the diseases common to nearly every family can be cured.

Neovia is a biotech freedom city on American federal land where the Prime Law replaces the decade-long regulatory toll, so the distance between a discovery and the patient it cures is measured in months instead of years.

America's Next Moonshot

Neovia sits in the arc of America's largest leaps. Detroit built more than cars; it built a middle class. Silicon Valley rewrote how the world thinks. Apollo unified national purpose and proved a hard target could be met on a deadline. Neovia is a leap of that scale, aimed at human health.

Neovia builds on Executive Order 14293, signed in May 2025, which cut red tape strangling domestic drug manufacturing. Reform alone will not win the biotech race: China has surpassed the United States in clinical trials for two consecutive years. The proposal is a new executive order establishing a Biotech Freedom Task Force in the West Wing, chaired by the National Security Advisor and vice-chaired by the Secretary of Health and Human Services, with Defense, Energy, Commerce, FDA, NIH, and CMS at the table. The timeline selects federal land and greenlights the first cohort of companies in 60 days, delivers the full phase-one plan in 90 days, and activates the virtual zone on day one.

Warp Biotech and the Prime Law

The Institute calls the operating system warp biotech, a framework built to collapse timelines from decades to months. It validates biomarkers and surrogate endpoints so promising therapies do not languish in decade-long trials, standardizes high-fidelity digital trials, and designates supervised experimental-use zones where regenerative, genetic, and AI-driven technologies are tested and scaled responsibly. Paired with that freedom are targeted incentives: research prioritization, tax relief for on-site build-out, and CMS payment models ready for the moment a therapy clears.

The backbone is the Prime Law: no person or institution may initiate force or fraud. The Prime Law pairs the prohibition on aggression with full personal responsibility, the governing principle that separates a city of chaos from a city of accelerated freedom.

The Mechanism Warp biotech collapses timelines from decades to months. The Prime Law is what makes that speed safe rather than reckless.

Sister Cities: The Global Pipeline

The Neovia vision begins on American soil and extends beyond it. Argentina, under President Javier Milei, offers an opening for research freedom. Neovia USA and Neovia Argentina, as sister cities, form a two-engine pipeline: accelerated research abroad and a rapid pathway to the American market and manufacturing base at home. Neovia Argentina can demonstrate at the survival level what liberty delivers in patient outcomes and household stability, and from that beachhead Prime Law freedom can spread industry by industry.

What Neovia Builds

Neovia is designed to beat China to the future of biotech by out-creating it, to secure American supply chains for critical medicines on domestic soil, to compress timelines from decades to years to months, and to cut costs while raising the quality of care by removing wasteful delay. It is built to create millions of jobs and to restore health and independence to seniors and families.

In a divided era, Neovia opens a rare bipartisan lane. Nine in ten Americans either suffer from a chronic disease or watch a loved one struggle, and a cure speaks to all of them. Curing age-related disease also reduces the fiscal load of rising healthcare costs, and as older Americans regain health many re-enter the workforce as makers of value rather than recipients of care.

Neovia is the operational answer to the question the Institute has been building toward across 50+ years of research: curing aging in a system built to prevent it. Neovia overcomes the two obstacles, stagnation and regulation, by building a zone where neither can operate.

Common Questions

What is Neovia? Neovia is a proposed biotech freedom city on American federal land where laboratories, manufacturing plants, and research campuses operate under one constitutional principle, the Prime Law. It is the discovery-to-deployment cure zone: a place engineered to compress the distance between a scientific discovery and the patient who needs it from a decade to months.

How is Neovia different from Immortalis? Immortalis is the end-vision civilization, the society designed from the ground up to remove initiated force as a governing principle. Neovia is the near-term zone that proves the principle in practice, beginning with medical cures. Immortalis is the theory made concrete at civilization scale; Neovia is the deployment vehicle that demonstrates it first in biotech.

What is warp biotech? Warp biotech is the operating system Neovia runs on, a framework built to collapse trial timelines from decades to months. It validates biomarkers and surrogate endpoints so promising therapies do not languish in decade-long trials, standardizes high-fidelity digital trials, and designates supervised experimental-use zones where regenerative, genetic, and AI-driven technologies are tested and scaled responsibly.

Why does Neovia begin with a virtual zone? The virtual zone delivers targeted regulatory relief, including accelerated approvals and fast-tracked reimbursement, the moment a company contracts to build. Therapies can reach Americans before the first brick is laid, so the cure pipeline opens on day one rather than waiting on construction.

What does the Prime Law do inside Neovia? The Prime Law states that no person or institution may initiate force or fraud, and it pairs that prohibition with full personal responsibility. Inside Neovia it is the governance mechanism that makes warp-biotech speed safe rather than reckless, the principle that separates a city of accelerated freedom from a city of chaos.

Why does the gap between cure and patient cost so much? A single therapy today costs one to two billion dollars and ten or more years to reach the patient, and most of that cost buys nothing but delay. Neovia removes the regulatory force that traps progress, which is the specific arithmetic the city is built to solve.

Further Reading